Company Filing History:
Years Active: 1991-1993
Title: The Innovations of Mohinder S Kang
Introduction
Mohinder S Kang is a notable inventor based in Cincinnati, OH, who has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, his work primarily focuses on the development of compounds that serve as inhibitors for various enzymes, showcasing his expertise in medicinal chemistry.
Latest Patents
Kang's latest patents include innovative compounds such as alpha-mannosidase inhibitors, specifically the [4S-(4.alpha.,4a.beta.,5.beta.,6.alpha.,7.alpha.,7a.alpha.)]-Octahydro-1H-1-pyrindine-4,5,6,7-tetrols and [4R-(4.alpha.,4a.alpha.,5.alpha.,6.beta.,7.beta.,7a.beta.)]-octahydro-1H-1-pyrindine-4,5,6,7-tetrols. These compounds are recognized for their utility as inhibitors of alpha-mannosidase and are valuable as immunostimulants, chemoprotective and radioprotective agents, as well as antimetastatic agents. Additionally, he has developed derivatives of 6-aminooctahydroindolizinetriol, including amide and ester derivatives, which are prepared from castanospermine by modifying hydroxy functions. These compounds are particularly useful as hexosaminidase inhibitors.
Career Highlights
Kang's career is marked by his role at Merrell Dow Pharmaceuticals, where he has been instrumental in advancing pharmaceutical research and development. His innovative approach to drug design has led to the creation of compounds that address critical health challenges.
Collaborations
Throughout his career, Kang has collaborated with esteemed colleagues such as Paul S Liu and Roland S Rogers. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Mohinder S Kang's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his significant impact on medicinal chemistry. His work continues to pave the way for advancements in therapeutic agents.